{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:03:46Z","timestamp":1789340626644,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222062"],"award-info":[{"award-number":["82222062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China"},{"name":"National Key R&D Program of Chin"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76313-w","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:23:34Z","timestamp":1786076614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The efficacy, immunogenicity and safety of the LZ901 vaccine for herpes zoster virus in adults 40 years of age or older: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7652-2591","authenticated-orcid":false,"given":"Pengfei","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3791-1241","authenticated-orcid":false,"given":"Hongxing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8938-5530","authenticated-orcid":false,"given":"Wenyan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-0564","authenticated-orcid":false,"given":"Yeqing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9778-7986","authenticated-orcid":false,"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4584-1965","authenticated-orcid":false,"given":"Songtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7033-5151","authenticated-orcid":false,"given":"Jingxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"76313_CR1","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1056\/NEJMcp1302674","volume":"369","author":"JI Cohen","year":"2013","unstructured":"Cohen, J. I. Herpes zoster. N. Engl. J. Med. 369, 1766\u20131767 (2013).","journal-title":"N. Engl. J. Med."},{"key":"76313_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.16","volume":"1","author":"AA Gershon","year":"2015","unstructured":"Gershon, A. A. et al. Varicella zoster virus infection. Nat. Rev. Dis. Primers 1, 15016 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"76313_CR3","first-page":"1","volume":"57","author":"R Harpaz","year":"2008","unstructured":"Harpaz, R., Ortega-Sanchez, I. R. & Seward, J. F. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 57, 1\u201330 (2008). quiz CE2-4.","journal-title":"MMWR Recomm. Rep."},{"key":"76313_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/2051013615599151","volume":"3","author":"RW Johnson","year":"2015","unstructured":"Johnson, R. W. et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther. Adv. Vaccines 3, 109\u2013120 (2015).","journal-title":"Ther. Adv. Vaccines"},{"key":"76313_CR5","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","volume":"371","author":"RW Johnson","year":"2014","unstructured":"Johnson, R. W. & Rice, A. S. Clinical practice. Postherpetic neuralgia. N. Engl. J. Med. 371, 1526\u20131533 (2014).","journal-title":"N. Engl. J. Med."},{"key":"76313_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet, M. et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ 182, 1731\u20131736 (2010).","journal-title":"CMAJ"},{"key":"76313_CR7","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai, K., Gebremeskel, B. G. & Acosta, C. J. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 4, e004833 (2014).","journal-title":"BMJ Open"},{"key":"76313_CR8","doi-asserted-by":"crossref","unstructured":"Valladales-Restrepo, L. F., Velasquez-Quimara, S. & Machado-Alba, J. E. Pharmacological treatment of herpes zoster and factors associated with its recurrence. Antibiotics 12, 757 (2023).","DOI":"10.3390\/antibiotics12040757"},{"key":"76313_CR9","doi-asserted-by":"publisher","first-page":"k4029","DOI":"10.1136\/bmj.k4029","volume":"363","author":"AC Tricco","year":"2018","unstructured":"Tricco, A. C. et al. Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. BMJ 363, k4029 (2018).","journal-title":"BMJ"},{"key":"76313_CR10","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman, M. N. et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352, 2271\u20132284 (2005).","journal-title":"N. Engl. J. Med."},{"key":"76313_CR11","unstructured":"Strezova, A. et al. Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications. EClinicalMedicine 83, 103241 (2025)."},{"key":"76313_CR12","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal, H. et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N. Engl. J. Med. 372, 2087\u20132096 (2015).","journal-title":"N. Engl. J. Med."},{"key":"76313_CR13","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham, A. L. et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N. Engl. J. Med. 375, 1019\u20131032 (2016).","journal-title":"N. Engl. J. Med."},{"key":"76313_CR14","unstructured":"Advisory Committee on Immunization Practices (ACIP). Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): recombinant zoster vaccine (RZV) and herpes zoster live-attenuated vaccine (ZVL). https:\/\/www.cdc.gov\/acip\/grade\/herpes-zoster.html (2024)."},{"key":"76313_CR15","doi-asserted-by":"crossref","unstructured":"Quan, Y. et al. Comparison of the immunogenicity of the LZ901 vaccine and HZ\/su vaccine in a mouse model. Vaccines 12, 775 (2024).","DOI":"10.3390\/vaccines12070775"},{"key":"76313_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62800-z","volume":"16","author":"PF Jin","year":"2025","unstructured":"Jin, P. F. et al. Immunogenicity and safety of a recombinant gE-Fc fusion protein subunit vaccine for herpes zoster in adults \u226550 years of age: a randomised, active-controlled, non-inferiority trial. Nat. Commun. 16, 7590 (2025).","journal-title":"Nat. Commun."},{"key":"76313_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-37","volume":"8","author":"RW Johnson","year":"2010","unstructured":"Johnson, R. W. et al. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 8, 37 (2010).","journal-title":"BMC Med."},{"key":"76313_CR18","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","volume":"183","author":"AM Didierlaurent","year":"2009","unstructured":"Didierlaurent, A. M. et al. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J. Immunol. 183, 6186\u20136197 (2009).","journal-title":"J. Immunol."},{"key":"76313_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","volume":"16","author":"AM Didierlaurent","year":"2017","unstructured":"Didierlaurent, A. M. et al. Adjuvant system AS01: helping to overcome the challenges of modern vaccines. Expert Rev. Vaccines 16, 55\u201363 (2017).","journal-title":"Expert Rev. Vaccines"},{"key":"76313_CR20","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.7326\/ANNALS-24-02409","volume":"178","author":"NA Vielot","year":"2025","unstructured":"Vielot, N. A. et al. Effectiveness of recombinant herpes zoster vaccine in the U.S. Medicare Population, 2018 to 2019, by immunocompetence and prior receipt of live zoster vaccine. Ann. Intern. Med. 178, 1728\u20131736 (2025).","journal-title":"Ann. Intern. Med."},{"key":"76313_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","volume":"30","author":"SG Reed","year":"2009","unstructured":"Reed, S. G., Bertholet, S., Coler, R. N. & Friede, M. New horizons in adjuvants for vaccine development. Trends Immunol. 30, 23\u201332 (2009).","journal-title":"Trends Immunol."},{"key":"76313_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nri2510","volume":"9","author":"P Marrack","year":"2009","unstructured":"Marrack, P., McKee, A. S. & Munks, M. W. Towards an understanding of the adjuvant action of aluminium. Nat. Rev. Immunol. 9, 287\u2013293 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"76313_CR23","doi-asserted-by":"publisher","first-page":"108005","DOI":"10.1016\/j.ijid.2025.108005","volume":"159","author":"Y Xia","year":"2025","unstructured":"Xia, Y. et al. Epidemiology of herpes zoster and post-herpetic neuralgia in China: A nationwide population-based survey. Int. J. Infect. Dis. 159, 108005 (2025).","journal-title":"Int. J. Infect. Dis."},{"key":"76313_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cmi.2025.09.009","volume":"32","author":"S Wang","year":"2026","unstructured":"Wang, S. et al. Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trial. Clin. Microbiol. Infect. 32, 128\u2013136 (2026).","journal-title":"Clin. Microbiol. Infect."},{"key":"76313_CR25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.vaccine.2015.09.073","volume":"34","author":"R Chlibek","year":"2016","unstructured":"Chlibek, R. et al. Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults. Vaccine 34, 863\u2013868 (2016).","journal-title":"Vaccine"},{"key":"76313_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1001\/jama.2019.9053","volume":"322","author":"A Bastidas","year":"2019","unstructured":"Bastidas, A. et al. Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial. JAMA 322, 123\u2013133 (2019).","journal-title":"JAMA"},{"key":"76313_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S1473-3099(19)30310-X","volume":"19","author":"KM Mullane","year":"2019","unstructured":"Mullane, K. M. et al. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial. Lancet Infect. Dis. 19, 1001\u20131012 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"76313_CR28","unstructured":"Yu, S. Chinese Expert Consensus on the Diagnosis and Treatment of Postherpetic Neuralgia. Chin. J. Pain Med. 22, 161\u2013167 (2016)."},{"key":"76313_CR29","first-page":"55","volume":"18","author":"GE Gross","year":"2020","unstructured":"Gross, G. E. et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia. J. Dtsch. Dermatol Ges. 18, 55\u201378 (2020).","journal-title":"J. Dtsch. Dermatol Ges."},{"key":"76313_CR30","unstructured":"NMPA. Standard guidelines for grading adverse events in clinical trials of prophylactic vaccines. https:\/\/www.nmpa.gov.cn\/xxgk\/ggtg\/ypggtg\/ypqtggtg\/20191231111901460.html (2019)."},{"key":"76313_CR31","unstructured":"WHO. The use of the WHO-UMC system for standardised case causality assessment. https:\/\/www.who.int\/publications\/m\/item\/WHO-causality-assessment (2013)."},{"key":"76313_CR32","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","volume":"17","author":"D van Oorschot","year":"2021","unstructured":"van Oorschot, D. et al. A systematic literature review of herpes zoster incidence worldwide. Hum. Vaccines Immunother. 17, 1714\u20131732 (2021).","journal-title":"Hum. Vaccines Immunother."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76313-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76313-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76313-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T22:35:41Z","timestamp":1789338941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76313-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76313"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76313-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9763"}}